Crossmark

The impact of sodium-glucose cotransporter-2 inhibitors on the incidence, therapy, and outcomes of fournier gangrene: insights from a systematic review of case reports

Crossref DOI link: https://doi.org/10.1186/s13643-024-02746-3

Published Online: 2025-01-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Azmi, Yufi Aulia

Alkaff, Firas F.

Soetanto, Kevin Muliawan

Wirjopranoto, Soetojo

Postma, Maarten J.

Purba, Abdul Khairul Rizki https://orcid.org/0000-0002-9372-2656
License Information

Text and Data Mining valid from 2025-01-27

Version of Record valid from 2025-01-27
More Information

Article History

Received: 13 August 2024

Accepted: 20 December 2024

First Online: 27 January 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below